UMich Rogel receives $11.1M SPORE for radiosensitization research

Temozolomide + radiation treatment improves OS for grade 2 gliomas

Both radiation and temozolomide, a generic chemotherapy treatment in pill form, have meaningful single-modality anti-tumor activity against slow-growing, low-grade gliomas.

December 06, 2024

Vol.50 No.45

In Brief

UCLA’s Luca Valle receives $2.1M grant from VA to improve prediction of radiorecurrent prostate cancer outcomes

Luca Valle, assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA, was awarded a $2.1 million grant from the U.S. Department of Veterans Affairs to develop new methods to better understand the clinical scope and biological factors that lead to prostate cancer coming back after radiation therapy.

October 25, 2024

Vol.50 No.40

In Brief

NCI funds $11.6M “Route 66” SPORE in endometrial cancer

NCI has awarded researchers at Washington University School of Medicine in St. Louis a Specialized Programs of Research Excellence grant to spur new strategies to prevent and treat endometrial cancer.

October 04, 2024

Vol.50 No.37

In Brief

UCSF Prostate Cancer Program receives $7M SPORE grant

The UCSF Prostate Cancer Program received the NCI’s Specialized Programs of Research Excellence, or SPORE, grant for prostate cancer.

September 06, 2024

Vol.50 No.33

In the Archives

The early days of EGFR: Herbst, Haber, Meyerson, Pao, Sequist present at Yale SPORE workshop

In 1998, lung cancer was the leading cause of cancer deaths in the United States, with 160,000 deaths per year. That statistic inspired Matthew Meyerson, who would soon start working at the Dana-Farber Cancer Institute, to specialize in lung cancer.

July 05, 2024

Vol.50 No.27

Clinical Roundup

ASTRO updates guideline on radiation therapy for HPV-related throat cancer

The American Society for Radiation Oncology published an updated clinical guideline in Practical Radiation Oncology that details best practices for using radiation therapy to treat patients who have oropharyngeal squamous cell carcinoma caused by the human papilloma virus.

June 21, 2024

Vol.50 No.25

UMich Rogel receives $11.1M SPORE for radiosensitization research

YOU MAY BE INTERESTED IN

Temozolomide + radiation treatment improves OS for grade 2 gliomas

UCLA’s Luca Valle receives $2.1M grant from VA to improve prediction of radiorecurrent prostate cancer outcomes

NCI funds $11.6M “Route 66” SPORE in endometrial cancer

UCSF Prostate Cancer Program receives $7M SPORE grant

The early days of EGFR: Herbst, Haber, Meyerson, Pao, Sequist present at Yale SPORE workshop

ASTRO updates guideline on radiation therapy for HPV-related throat cancer

Renew today!

Subscriber content

Never miss an issue!

Login